Reuters logo
BRIEF-Hemispherx Biopharma says obtained omnibus assignment of all IP rights of ex-CEO Carter
2016年6月6日 / 下午12点57分 / 1 年前

BRIEF-Hemispherx Biopharma says obtained omnibus assignment of all IP rights of ex-CEO Carter

June 6 (Reuters) - Hemispherx Biopharma :

* Hemispherx Biopharma Inc says on June 2, obtained omnibus assignment of all intellectual property rights of former CEO William Carter

* All IP related to Ampligen and Alferon that was created by Carter prior to and during his employment at Hemispherx has now been assigned to Hemispherx Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below